{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T19:23:55Z","timestamp":1793733835270,"version":"4.6.1"},"reference-count":31,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["GM142992"],"award-info":[{"award-number":["GM142992"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["HL140026"],"award-info":[{"award-number":["HL140026"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["GM142992"],"award-info":[{"award-number":["GM142992"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["HL140026"],"award-info":[{"award-number":["HL140026"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.atsjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,3,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Rationale<\/jats:title>\n                    <jats:p>Systemic molecular phenotypes of critical illness are prognostically informative, yet their temporal kinetics and implications of changing phenotypes remain incompletely understood.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>To determine the temporal nature of the Hyperinflammatory and Hypoinflammatory phenotypes and assess the impact of transition between the phenotypes on mortality.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We used data from one prospective observational cohort (MARS [Molecular Diagnosis and Risk Stratification of Sepsis]) and two randomized controlled trials in acute respiratory distress syndrome (ALVEOLI [Assessment of Low Tidal Volume and Elevated End-Expiratory Pressure to Obviate Lung Injury]) and sepsis (CLOVERS [Crystalloid Liberal or Vasopressors Early Resuscitation in Sepsis]). Critically ill patients with biomarkers available at multiple time points (Days 0\u20134) were included. We used a validated classifier model incorporating plasma IL-8, protein C, and serum bicarbonate to assign phenotypes on each day. We determined the association of longitudinal phenotype transition and 90-day all-cause mortality.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Measurements and Main Results<\/jats:title>\n                    <jats:p>Data from 2,407, 527, and 868 patients were included in MARS, ALVEOLI, and CLOVERS, respectively. In MARS, 36.0% were classified by the parsimonious model as Hyperinflammatory at Day 0, decreasing to 15.6% by Day 2 and 6.3% by Day 4. In ALVEOLI and CLOVERS, 26.4% and 24.8% of patients were Hyperinflammatory at Day 0, decreasing to 13.4% and 5.7% at Day 3, respectively. In all three cohorts, switching classification from Hyperinflammatory (Day 0) to Hypoinflammatory over time was associated with significantly improved mortality compared with persistently Hyperinflammatory patients. Mediation analysis indicated that only a minor proportion of this improvement could be attributed to ameliorating organ failure.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The prevalence of the Hyperinflammatory phenotype, as assigned using a parsimonious biomarker classifier model, decreases over the first several days of critical illness, irrespective of acute respiratory distress syndrome diagnosis. The transition from Hyperinflammatory to Hypoinflammatory mediates a trajectory toward recovery beyond the resolution of organ failure.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1164\/rccm.202406-1241oc","type":"journal-article","created":{"date-parts":[[2024,12,6]],"date-time":"2024-12-06T16:26:32Z","timestamp":1733502392000},"page":"347-356","update-policy":"https:\/\/doi.org\/10.1164\/crossmarkpolicies","source":"Crossref","is-referenced-by-count":62,"title":["Temporal Transitions of the Hyperinflammatory and Hypoinflammatory Phenotypes in Critical Illness"],"prefix":"10.1093","volume":"211","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9296-8518","authenticated-orcid":false,"given":"Rombout B. E.","family":"van Amstel","sequence":"first","affiliation":[{"name":"Department of Intensive Care Medicine and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Bartek","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, School of Medicine, Washington University, St. Louis, Missouri"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3453-7186","authenticated-orcid":false,"given":"Alexander P. J.","family":"Vlaar","sequence":"additional","affiliation":[{"name":"Department of Intensive Care Medicine and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Gay","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, School of Medicine, Washington University, St. Louis, Missouri"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lonneke A.","family":"van Vught","sequence":"additional","affiliation":[{"name":"Department of Intensive Care Medicine and"},{"name":"Center for Experimental and Molecular Medicine, Amsterdam Infection and Immunity, Amsterdam University Medical Center, location University of Amsterdam, Amsterdam, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olaf L.","family":"Cremer","sequence":"additional","affiliation":[{"name":"Department of Intensive Care, University Medical Center Utrecht, Utrecht, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom","family":"Van der Poll","sequence":"additional","affiliation":[{"name":"Center for Experimental and Molecular Medicine, Amsterdam Infection and Immunity, Amsterdam University Medical Center, location University of Amsterdam, Amsterdam, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathan I.","family":"Shapiro","sequence":"additional","affiliation":[{"name":"Department of Emergency Medicine, Beth Israel Deaconess Medical Center, Boston, Massachusetts; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael A.","family":"Matthay","sequence":"additional","affiliation":[{"name":"Division of Pulmonary, Critical Care, Allergy and Sleep Medicine, University of California, San Francisco, San Francisco, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolyn S.","family":"Calfee","sequence":"additional","affiliation":[{"name":"Division of Pulmonary, Critical Care, Allergy and Sleep Medicine, University of California, San Francisco, San Francisco, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pratik","family":"Sinha","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, School of Medicine, Washington University, St. Louis, Missouri"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lieuwe D. J.","family":"Bos","sequence":"additional","affiliation":[{"name":"Department of Intensive Care Medicine and"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,3,1]]},"reference":[{"key":"2026031105225193800_bib1","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1164\/rccm.201512-2544CP","article-title":"Toward smarter lumping and smarter splitting: rethinking strategies for sepsis and acute respiratory distress syndrome clinical trial design","volume":"194","author":"Prescott","year":"2016","journal-title":"Am J Respir Crit Care Med"},{"key":"2026031105225193800_bib2","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/S2213-2600(23)00237-0","article-title":"Identifying molecular phenotypes in sepsis: an analysis of two prospective observational cohorts and secondary analysis of two randomised controlled trials","volume":"11","author":"Sinha","year":"2023","journal-title":"Lancet Respir Med"},{"key":"2026031105225193800_bib3","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/S2213-2600(21)00461-6","article-title":"Validation and utility of ARDS subphenotypes identified by machine-learning models using clinical data: an observational, multicohort, retrospective analysis","volume":"10","author":"Maddali","year":"2022","journal-title":"Lancet Respir Med"},{"key":"2026031105225193800_bib4","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/S2213-2600(14)70097-9","article-title":"Subphenotypes in acute respiratory distress syndrome: latent class analysis of data from two randomised controlled trials","volume":"2","author":"Calfee","year":"2014","journal-title":"Lancet Respir Med"},{"key":"2026031105225193800_bib5","doi-asserted-by":"crossref","first-page":"e066496","DOI":"10.1136\/bmjopen-2022-066496","article-title":"Rapid Recognition of Corticosteroid Resistant or Sensitive Sepsis (RECORDS): study protocol for a multicentre, placebo-controlled, biomarker-guided, adaptive Bayesian design basket trial","volume":"13","author":"Fleuriet","year":"2023","journal-title":"BMJ Open"},{"key":"2026031105225193800_bib6","doi-asserted-by":"crossref","first-page":"e067251","DOI":"10.1136\/bmjopen-2022-067251","article-title":"ImmunoSep (Personalised Immunotherapy in Sepsis) international double-blind, double-dummy, placebo-controlled randomised clinical trial: study protocol","volume":"12","author":"Kotsaki","year":"2022","journal-title":"BMJ Open"},{"key":"2026031105225193800_bib7","author":"European Respiratory Society","year":"2024"},{"key":"2026031105225193800_bib8","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1136\/thoraxjnl-2017-211090","article-title":"Stability of ARDS subphenotypes over time in two randomised controlled trials","volume":"73","author":"Delucchi","year":"2018","journal-title":"Thorax"},{"key":"2026031105225193800_bib9","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/S2213-2600(19)30369-8","article-title":"Development and validation of parsimonious algorithms to classify acute respiratory distress syndrome phenotypes: a secondary analysis of randomised controlled trials","volume":"8","author":"Sinha","year":"2020","journal-title":"Lancet Respir Med"},{"key":"2026031105225193800_bib10","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/S2213-2600(17)30188-1","article-title":"Clinical trials in acute respiratory distress syndrome: challenges and opportunities","volume":"5","author":"Matthay","year":"2017","journal-title":"Lancet Respir Med"},{"key":"2026031105225193800_bib11","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1007\/s00134-023-07050-7","article-title":"ESICM guidelines on acute respiratory distress syndrome: definition, phenotyping and respiratory support strategies","volume":"49","author":"Grasselli","year":"2023","journal-title":"Intensive Care Med"},{"key":"2026031105225193800_bib12","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1177\/08850666231153393","article-title":"Evolution of clinical phenotypes of COVID-19 patients during intensive care treatment: an unsupervised machine learning analysis","volume":"38","author":"Siepel","year":"2023","journal-title":"J Intensive Care Med"},{"key":"2026031105225193800_bib13","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1016\/S2213-2600(17)30294-1","article-title":"Classification of patients with sepsis according to blood genomic endotype: a prospective cohort study","volume":"5","author":"Scicluna","year":"2017","journal-title":"Lancet Respir Med"},{"key":"2026031105225193800_bib14","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1136\/thoraxjnl-2016-209719","article-title":"Identification and validation of distinct biological phenotypes in patients with acute respiratory distress syndrome by cluster analysis","volume":"72","author":"Bos","year":"2017","journal-title":"Thorax"},{"key":"2026031105225193800_bib15","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.1097\/CCM.0b013e3182923712","article-title":"Interobserver agreement of Centers for Disease Control and Prevention criteria for classifying infections in critically ill patients","volume":"41","author":"Klein Klouwenberg","year":"2013","journal-title":"Crit Care Med"},{"key":"2026031105225193800_bib16","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1056\/NEJMoa032193","article-title":"Higher versus lower positive end-expiratory pressures in patients with the acute respiratory distress syndrome","volume":"351","author":"Brower","year":"2004","journal-title":"N Engl J Med"},{"key":"2026031105225193800_bib17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/01.CCM.0000149854.61192.DC","article-title":"Lower tidal volume ventilation and plasma cytokine markers of inflammation in patients with acute lung injury","volume":"33","author":"Parsons","year":"2005","journal-title":"Crit Care Med"},{"key":"2026031105225193800_bib18","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1056\/NEJMoa2212663","article-title":"Early restrictive or liberal fluid management for sepsis-induced hypotension","volume":"388","author":"Shapiro","year":"2023","journal-title":"N Engl J Med"},{"key":"2026031105225193800_bib19","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1164\/rccm.202006-2522OC","article-title":"Biological subphenotypes of ARDS show prognostic enrichment in mechanically ventilated patients without ARDS","volume":"203","author":"Heijnen","year":"2021","journal-title":"Am J Respir Crit Care Med"},{"key":"2026031105225193800_bib20","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1164\/rccm.202308-1490OC","article-title":"Molecular phenotypes of ARDS in the ROSE trial have differential outcomes and gene expression patterns that differ at baseline and longitudinally over time","volume":"209","author":"Sinha","year":"2024","journal-title":"Am J Respir Crit Care Med"},{"key":"2026031105225193800_bib21","doi-asserted-by":"crossref","first-page":"100018","DOI":"10.1016\/j.chstcc.2023.100018","article-title":"Trajectories of host-response subphenotypes in patients with COVID-19 across the spectrum of respiratory support","volume":"1","author":"Lu","year":"2023","journal-title":"CHEST Crit Care"},{"key":"2026031105225193800_bib22","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1378\/chest.108.5.1303","article-title":"Inflammatory cytokines in the BAL of patients with ARDS: persistent elevation over time predicts poor outcome","volume":"108","author":"Meduri","year":"1995","journal-title":"Chest"},{"key":"2026031105225193800_bib23","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1097\/CCM.0000000000000100","article-title":"Immunological characterization of compensatory anti-inflammatory response syndrome in patients with severe sepsis: a longitudinal study","volume":"42","author":"Gomez","year":"2014","journal-title":"Crit Care Med"},{"key":"2026031105225193800_bib24","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1016\/S2213-2600(21)00365-9","article-title":"Longitudinal respiratory subphenotypes in patients with COVID-19-related acute respiratory distress syndrome: results from three observational cohorts","volume":"9","author":"Bos","year":"2021","journal-title":"Lancet Respir Med"},{"key":"2026031105225193800_bib25","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1164\/rccm.201806-1197OC","article-title":"Identifying novel sepsis subphenotypes using temperature trajectories","volume":"200","author":"Bhavani","year":"2019","journal-title":"Am J Respir Crit Care Med"},{"key":"2026031105225193800_bib26","doi-asserted-by":"crossref","first-page":"e072883","DOI":"10.1136\/bmj-2022-072883","article-title":"On the 12th day of Christmas, a statistician sent to me","volume":"379","author":"Riley","year":"2022","journal-title":"BMJ"},{"key":"2026031105225193800_bib27","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1164\/rccm.201603-0645OC","article-title":"Acute respiratory distress syndrome subphenotypes respond differently to randomized fluid management strategy","volume":"195","author":"Famous","year":"2017","journal-title":"Am J Respir Crit Care Med"},{"key":"2026031105225193800_bib28","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1007\/s00134-018-5378-3","article-title":"Latent class analysis of ARDS subphenotypes: a secondary analysis of the statins for acutely injured lungs from sepsis (SAILS) study","volume":"44","author":"Sinha","year":"2018","journal-title":"Intensive Care Med"},{"key":"2026031105225193800_bib29","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/S2213-2600(18)30177-2","article-title":"Acute respiratory distress syndrome subphenotypes and differential response to simvastatin: secondary analysis of a randomised controlled trial","volume":"6","author":"Calfee","year":"2018","journal-title":"Lancet Respir Med"},{"key":"2026031105225193800_bib30","doi-asserted-by":"crossref","first-page":"2200780","DOI":"10.1183\/13993003.00780-2022","article-title":"immunomodulation and endothelial barrier protection mediate the association between oral imatinib and mortality in hospitalised COVID-19 patients","volume":"60","author":"de Brabander","year":"2022","journal-title":"Eur Respir J"},{"key":"2026031105225193800_bib31","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1007\/s00134-017-4859-0","article-title":"Should we rely on trials with disease- rather than patient-oriented endpoints?","volume":"44","author":"de Grooth","year":"2018","journal-title":"Intensive Care Med"}],"container-title":["American Journal of Respiratory and Critical Care Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ajrccm\/article-pdf\/211\/3\/347\/67294421\/ajrccm_211_3_347.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ajrccm\/article-pdf\/211\/3\/347\/67294421\/ajrccm_211_3_347.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T09:23:01Z","timestamp":1773220981000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ajrccm\/article\/211\/3\/347\/8513452"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,1]]},"references-count":31,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2025,3,1]]},"published-print":{"date-parts":[[2025,3,1]]}},"URL":"https:\/\/doi.org\/10.1164\/rccm.202406-1241oc","relation":{},"ISSN":["1073-449X","1535-4970"],"issn-type":[{"value":"1073-449X","type":"print"},{"value":"1535-4970","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,3]]},"published":{"date-parts":[[2025,3,1]]},"assertion":[{"value":"2024-06-25","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-12-06","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-02-28","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}